The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
Open accessAbstract
Type 1 diabetes (T1D) is a debilitating autoimmune disease that results from T-cell-mediated destruction of insulin-producing beta-cells. Its incidence has increased during the past several decades in developed countries, suggesting that changes in the environment (including the human microbial environment) may influence disease pathogenesis. The incidence of spontaneous T1D in non-obese diabetic (NOD) mice can be affected by the microbial environment in the animal housing facility or by exposure to microbial stimuli, such as injection with mycobacteria or various microbial products. Here we show that specific pathogen-free NOD mice lacking MyD88 protein (an adaptor for multiple innate immune receptors that recognize microbial stimuli) do not develop T1D. The effect is dependent on commensal microbes because germ-free MyD88-negative NOD mice develop robust diabetes, whereas colonization of these germ-free MyD88-negative NOD mice with a defined microbial consortium (representing bacterial phyla normally present in human gut) attenuates T1D. We also find that MyD88 deficiency changes the composition of the distal gut microbiota, and that exposure to the microbiota of specific pathogen-free MyD88-negative NOD donors attenuates T1D in germ-free NOD recipients. Together, these findings indicate that interaction of the intestinal microbes with the innate immune system is a critical epigenetic factor modifying T1D predisposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mice deficient in MyD88 display an altered microbiota composition.56”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [56]
In the citing paper
“TLR5 is of particular importance in shaping the gut microbiota,53–56 which might be confined to a critical time window during neonatal life.40”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [56]
In the citing paper
“GF non-obese diabetic mice lacking MyD88 signaling robustly develop T1D”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [56]
In the citing paper
“while microbial colonization of these mice attenuates the disease.56”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [56]
In the citing paper
“Changes in the proportions of specific taxa of gut microbiota have been observed in various disease states, including obesity68,69, inflammatory bowel disease70, type 1 and type 2 diabetes mellitus71,72, biliary disease73, and intestinal cancers74,75 among many others.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [71]
In the citing paper
“there is evidence that particular population changes are associated with pathologies that confer an increased risk of developing PH and other vascular disease, including obesity[273–275], diabetes[276], and insulin resistance[277].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [276]
In the citing paper
“Elevations in the Firmicutes:Bacteroidetes ratio have been associated with a high-fat diet and obesity[274,328,329], irritable bowel syndrome[330], hypertension[331], type 1 diabetes[276], and HIV[332].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [276]
In the citing paper
“The Muc2-KO mouse possesses a distinct gut-associated bacterial community that is influenced by its altered genetic and immune states, as has been shown in other genetic knockout mouse models.4,53–55”
From Using Corticosteroids to Reshape the Gut Microbiome: Implications for Inflammatory Bowel Diseases (2015) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naive Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 20,145
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Self-citationPathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 12,401
16S ribosomal DNA amplification for phylogenetic study
Weisburg, W. G., Barns, S. M., Pelletier, D. A., & Lane, D. J. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.2.697-703.1991 · Cited by 11,970
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Self-citationUniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
ARB: a software environment for sequence data
Ludwig, W. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh293 · Cited by 6,714
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Self-citationRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Approaching the asymptote? Evolution and revolution in immunology.Preprint
Janeway, C. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,396
Research works printed but not linked: 1
- Funda, D. P., Fundova, P. & Harrison, L. C. Microflora-dependency of selected diabetes-preventive diets: germ-free and ex-germ-free monocolonized NOD mice as models for studying environmental factors in type 1 diabetes. Proc. 13th Int. Congr. Immunol. MS-11.4 16 (Brazilian Society for Immunology, Rio de Janeiro, 2007)
Cited by
Sorted by citations
Items 701–800 of 1,002
Takeshita, T., Suzuki, N., Nakano, Y., Shimazaki, Y., Yoneda, M., Hirofuji, T., & Yamashita, Y. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.02304-09 · Cited by 66
Goodwin, G. (2019) · Hormone Research in Paediatrics · doi:10.1159/000503142 · Cited by 67
Antigen presentation events in autoimmune diabetes
Calderón, B., & Unanue, E. R. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.11.005 · Cited by 65
Microbial Determinants of Biochemical Individuality and Their Impact on Toxicology and Pharmacology
Patterson, A. D., & Turnbaugh, P. J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.002 · Cited by 66
Li, H., Matte-Martone, C. C., Tan, H. S., Venkatesan, S., McNiff, J. M., Demetris, A. J., Jain, D., Lakkis, F. G., Rothstein, D. M., & Shlomchik, W. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002965 · Cited by 66
Bacterial Signaling at the Intestinal Epithelial Interface in Inflammation and Cancer
Coleman, O. I., & Haller, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01927 · Cited by 66
Probiotic species in the modulation of the anticancer immune response
Marinelli, L., Tenore, G. C., & Novellino, E. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.007 · Cited by 64
Brown, E., Arrieta, M., & Finlay, B. B. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.09.003 · Cited by 68
Ohnmacht, C., Marques, R., Presley, L. L., Sawa, S., Lochner, M., & Eberl, G. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01577.x · Cited by 67
Human Microbiome: When a Friend Becomes an Enemy
Muszer, M., Noszczyńska, M., Kasperkiewicz, K., & Skurnik, M. (2015) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0332-3 · Cited by 65
López, P., González-Rodríguez, I., Sánchez, B., Ruas‐Madiedo, P., Suárez, A., Margollés, A., & Gueimonde, M. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.07581-11 · Cited by 64
Phosphorylated Dihydroceramides from Common Human Bacteria Are Recovered in Human Tissues
Nichols, F. C., Yao, X., Bajrami, B., Downes, J., Finegold, S. M., Knee, E., Gallagher, J. J., Housley, W. J., & Clark, R. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016771 · Cited by 64
Role of Viruses and Other Microbes in the Pathogenesis of Type 1 Diabetes
Kondrashova, A., & Hyöty, H. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2014.889130 · Cited by 68
Plé, C., Breton, J., Richoux, R., Nurdin, M., Deutsch, S., Falentin, H., Hervé, C., Chuat, V., Lemée, R., Maguin, E., et al. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500580 · Cited by 64
Dietary short-chain fatty acids protect against type 1 diabetes
Li, W., & Wong, F. S. (2017) · Nature Immunology · doi:10.1038/ni.3730 · Cited by 64
Self-citationPublic health relevance of drug–nutrition interactions
Péter, S., Navis, G. J., de Borst, M. H., von Schacky, C., van Orten-Luiten, A. C. B., Zhernakova, A., Witkamp, R. F., Janse, A., Weber, P., Bakker, S. J. L., et al. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1510-3 · Cited by 68
Current understanding of the role of gut dysbiosis in type 1 diabetes
Abdellatif, A. M., & Sarvetnick, N. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12915 · Cited by 65
Reyes-Castillo, Z., Miramontes, E. H. V., Llamas-Covarrubias, M. A., & Muñóz-Valle, J. F. (2020) · Clinical and Experimental Medicine · doi:10.1007/s10238-020-00647-y · Cited by 64
Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial
Assfalg, R., Knoop, J., Hoffman, K. L., Pfirrmann, M., Zapardiel‐Gonzalo, J., Hofelich, A., Eugster, A., Weigelt, M., Matzke, C., Reinhardt, J., et al. (2021) · Diabetologia · doi:10.1007/s00125-020-05376-1 · Cited by 68
Zhou, Y., Lin, F., Cui, Z., Zhang, X., Hu, C., Tian, S., 陈春燕, Zhang, X., & Guo, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124194 · Cited by 64
Self-citationMa, W., Chen, J., Meng, Y., Yang, J., Cui, Q., & Zhou, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01336 · Cited by 64
Zhou, W., Chen, G., Chen, D., Ye, H., & Zeng, X. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104222 · Cited by 66
Nevius, E., Srivastava, P. K., & Basu, S. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.50 · Cited by 63
The role of commensal bacteria in the regulation of sensitization to food allergens
Cao, S. Z., Feehley, T., & Nagler‐Anderson, C. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.026 · Cited by 67
Effects of hexavalent chromium on intestinal histology and microbiota in Bufo gargarizans tadpoles
Yao, Q., Yang, H., Wang, X., & Wang, H. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.10.147 · Cited by 63
Tousen, Y., Matsumoto, Y., Nagahata, Y., Kobayashi, I., Inoue, M., & Ishimi, Y. (2019) · Nutrients · doi:10.3390/nu11020297 · Cited by 64
Palma, G. D., Capilla, A., Nadal, I., Nova, E., Pozo, T., Varea, V., Polanco, I., Castillejo, G., López, A., Garrote, J. A., et al. (2010) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · Cited by 63
Yamagishi, J., Sato, Y., Shinozaki, N. O., Ye, B., Tsuboi, A., Nagasaki, M., & Yamashita, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154389 · Cited by 66
Pan, W. D., & Kang, Y. (2017) · International Urology and Nephrology · doi:10.1007/s11255-017-1689-5 · Cited by 62
The Microbiota, the Immune System and the Allograft
Alegre, M.-L., Mannon, R. B., & Mannon, P. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12760 · Cited by 65
The human microbiome is a source of therapeutic drug targets
Wallace, B. D., & Redinbo, M. R. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.04.011 · Cited by 62
Fukuda, S., Nakanishi, Y., Chikayama, E., Ohno, H., Hino, T., & Kikuchi, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004893 · Cited by 64
The Role of the gut Microbiome in the Pathogenesis and Treatment of Obesity
Okeke, F. C., Roland, B. C., & Mullin, G. E. (2014) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2014.018 · Cited by 63
Drosophila as a model for intestinal dysbiosis and chronic inflammatory diseases
Lee, K., & Lee, W. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.05.005 · Cited by 64
Immune recognition and response to the intestinal microbiome in type 1 diabetes
Paun, A., Yau, C., & Danska, J. S. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.02.004 · Cited by 67
Use of antibiotics in childhood and risk of Type 1 diabetes: a population‐based case–control study
Mikkelsen, S. U., Knop, F. K., Vilsbøll, T., Frost, M., Hallas, J., & Pottegård, A. (2016) · Diabetic Medicine · doi:10.1111/dme.13262 · Cited by 67
Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis
Czaja, A. J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i42.9257 · Cited by 63
Mast cells at the crossroads of microbiota and IBD
Zuani, M. D., Secco, C. D., & Frossi, B. (2018) · European Journal of Immunology · doi:10.1002/eji.201847504 · Cited by 62
Association of Sjögren's Syndrome With Reduced Lifetime Sex Hormone Exposure: A Case–Control Study
McCoy, S. S., Sampene, E., & Baer, A. N. (2019) · Arthritis Care & Research · doi:10.1002/acr.24014 · Cited by 63
Decoding inflammation, its causes, genomic responses, and emerging countermeasures
Hawiger, J., & Zienkiewicz, J. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12812 · Cited by 62
Moshkelgosha, S., Masetti, G., Berchner‐Pfannschmidt, U., Verhasselt, H. L., Horstmann, M., Díaz‐Cano, S. J., Noble, A., Edelman, B., Covelli, D., Plummer, S. F., et al. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0653-3766 · Cited by 61
Yu, B., Zhang, D., Wu, Y., Wei, T., Luorong, Q., Luo, J., Tan, L., Chen, H., & Cao, W. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.135917 · Cited by 61
Tanoue, T., & Honda, K. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.11.009 · Cited by 62
Toll‐Like Receptors and Diabetes
Wong, F. S., & Li, W. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.063 · Cited by 61
Self-citationEkmekçiu, I., von Klitzing, E., Fiebiger, U., Neumann, C., Bächer, P., Scheffold, A., Bereswill, S., & Heimesaat, M. M. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00167 · Cited by 62
Rolig, A. S., Sweeney, E. G., Kaye, L. E., DeSantis, M. D., Perkins, A., Banse, A. V., Hamilton, M. K., & Guillemin, K. J. (2018) · eLife · doi:10.7554/elife.37172 · Cited by 61
Gut Microbiota, a Potential New Target for Chinese Herbal Medicines in Treating Diabetes Mellitus
Zhang, B., Yue, R., Chen, Y., Yang, M., Huang, X., Shui, J., Peng, Y., & Chin, J. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2634898 · Cited by 62
The Gut Microbiome of Adults With Type 1 Diabetes and Its Association With the Host Glycemic Control
Shilo, S., Godneva, A., Rachmiel, M., Korem, T., Bussi, Y., Kolobkov, D., Karady, T., Bar, N., Wolf, B. C., Glantz-Gashai, Y., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1656 · Cited by 60
Agus, A., Massier, S., Darfeuille–Michaud, A., Billard, E., & Barnich, N. (2014) · BioMed Research International · doi:10.1155/2014/567929 · Cited by 78
Relationship between intestinal microbiota and colorectal cancer
Çıpe, G., İdiz, U. O., Fırat, Y. D., & Bektaşoğlu, H. K. (2015) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v7.i10.233 · Cited by 60
The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis
Needell, J. C., & Zipris, D. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0781-z · Cited by 60
Hygiene and Other Early Childhood Influences on the Subsequent Function of the Immune System
Rook, G. A. W. (2011) · Digestive Diseases · doi:10.1159/000323877 · Cited by 60
Al-Khafaji, A. H., Jepsen, S. D., Christensen, K. R., & Vigsnæs, L. K. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104176 · Cited by 62
Gut Microbiota and Type 1 Diabetes Mellitus: The Effect of Mediterranean Diet
Calabrese, C. M., Valentini, A., & Calabrese, G. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2020.612773 · Cited by 58
Long, Y., & Luo, J. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.2998906 · Cited by 59
Chemoprevention in Gastrointestinal Physiology and Disease. Natural products and microbiome
Greiner, A. K., Papineni, R. V. L., & Umar, S. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00044.2014 · Cited by 60
Hasegawa, M., Osaka, T., Tawaratsumida, K., Yamazaki, T., Tada, H., Chen, G., Tsuneda, S., Núñez, G., & Inohara, N. (2009) · Infection and Immunity · doi:10.1128/iai.01043-09 · Cited by 58
NLR and Intestinal Dysbiosis-Associated Inflammatory Illness: Drivers or Dampers?
Elias‐Oliveira, J., Leite, J. A., Pereira, Í. S., Guimarães, J. B., Manso, G. M. D. C., Silva, J. S., Tostes, R. C., & Carlos, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01810 · Cited by 59
Gut microbiota in pancreatic diseases: possible new therapeutic strategies
Pan, L., Li, B., Pan, X., & Sun, J. T. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00532-0 · Cited by 61
Elevated trimethylamine N -oxide related to ischemic brain lesions after carotid artery stenting
Wu, C., Li, C., Zhao, W., Xie, N., Yan, F., Lian, Y., Zhou, L., Xu, X., Liang, Y., Wang, L., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005298 · Cited by 58
Exploring the Gut Microbiome in Myasthenia Gravis
Thye, A. Y.-K., Law, J. W., Tan, L. T., Thurairajasingam, S., Chan, K., Letchumanan, V., & Lee, L. (2022) · Nutrients · doi:10.3390/nu14081647 · Cited by 61
Zhu, H., Hao, H., & Yu, L. (2024) · BMC Biology · doi:10.1186/s12915-024-01968-0 · Cited by 57
The human intestinal microbiota
Dore, J. M., & Corthier, G. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(10)70015-4 · Cited by 67
Gut Microbes: From Bugs to Drugs
Shanahan, F. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.729 · Cited by 57
Patrick, C., Wang, G., Lefebvre, D. E., Crookshank, J. A., Sonier, B., Eberhard, C. E., Mojibian, M., Kennedy, C., Brooks, S. P. J., Kalmokoff, M. L., et al. (2013) · Diabetes · doi:10.2337/db12-1243 · Cited by 57
Th17 Cells in Type 1 Diabetes: Role in the Pathogenesis and Regulation by Gut Microbiome
Li, Y., Liu, Y., & Chu, C. (2015) · Mediators of Inflammation · doi:10.1155/2015/638470 · Cited by 60
Editorial: The Wildlife Gut Microbiome and Its Implication for Conservation Biology
Zhu, L., Wang, J., & Bahrndorff, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.697499 · Cited by 57
Paul, S. S., Rao, S. V. R., Hegde, N. R., Williams, N. J., CHATTERJEE, R. N., Raju, M. V. L. N., Reddy, G. N., Kumar, V., Kumar, P. S. P., Mallick, S., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.905050 · Cited by 57
Microbiota—implications for immunity and transplantation
Bromberg, J. S., Fricke, W. F., Brinkman, C. C., Simon, T., & Mongodin, E. F. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.70 · Cited by 56
An update on the use of NOD mice to study autoimmune (Type 1) diabetes
Chaparro, R. J., & DiLorenzo, T. P. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.68 · Cited by 58
Immune and genetic gardening of the intestinal microbiome
Jacobs, J. P., & Braun, J. G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.052 · Cited by 60
Isolation and Flow Cytometric Characterization of Murine Small Intestinal Lymphocytes
Couter, C. J., & Surana, N. K. (2016) · Journal of Visualized Experiments · doi:10.3791/54114 · Cited by 56
Botticelli, A., Zizzari, I. G., Mazzuca, F., Ascierto, P. A., Putignani, L., Marchetti, L., Napoletano, C., Nuti, M., & Marchetti, P. (2016) · Oncotarget · doi:10.18632/oncotarget.12985 · Cited by 57
Zhang, X., Yin, Y. S., Wang, J., Battaglia, T., Krautkramer, K. A., Li, W. V., Li, J., Brown, M., Zhang, M., Badri, M. H., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.014 · Cited by 58
Simon, K., Reilingh, G. D. V., Kemp, B., & Lammers, A. (2014) · Poultry Science · doi:10.3382/ps.2014-04225 · Cited by 55
Suppression of TLR Signaling by Targeting TIR domain-Containing Proteins
Fekonja, O., Avbelj, M., & Jerala, R. (2012) · Current Protein and Peptide Science · doi:10.2174/138920312804871148 · Cited by 56
Rivas, M. N., Koh, Y. T., Chen, A., Nguyen, A. L., Lee, Y., Lawson, G., & Chatila, T. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci40591 · Cited by 55
Connell, S., Meade, K. G., Allan, B. J., Lloyd, A. T., Kenny, E. M., Cormican, P., Morris, D. W., Bradley, D. G., & O’Farrelly, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040409 · Cited by 57
Hecht, G., Bar-Nathan, C., Milite, G. P., Alon, I., Moshe, Y., Greenfeld, L., Dotsenko, N., Suez, J., Levy, M., Thaiss, C. A., et al. (2014) · Laboratory Animals · doi:10.1177/0023677214544728 · Cited by 56
Hevia, A., Delgado, S., Margollés, A., & Sánchez, B. (2015) · Scientific Reports · doi:10.1038/srep16807 · Cited by 56
Tackling probiotic and gut microbiota functionality through proteomics
Ruíz, L., Hidalgo-Cantabrana, C., Blanco‐Míguez, A., Lourenço, A. M. G., Sánchez, B., & Margollés, A. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.03.023 · Cited by 56
Gülden, E., Chao, C., Tai, N., Pearson, J. A., Peng, J., Majewska‐Szczepanik, M., Zhou, Z., Wong, F. S., & Li, W. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.06.003 · Cited by 55
Self-citationGut microbiota in children and altered profiles in juvenile idiopathic arthritis
Filippo, C. D., Paola, M. D., Giani, T., Tirelli, F., & Cimaz, R. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.01.001 · Cited by 58
Ma, B. W., Bokulich, N. A., Castillo, P. A., Kananurak, A., Underwood, M. A., Mills, D. A., & Bevins, C. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047416 · Cited by 59
T‐cell selection and intestinal homeostasis
Ai, T. L., Solomon, B. D., & Hsieh, C. (2014) · Immunological Reviews · doi:10.1111/imr.12171 · Cited by 57
The role of the activating receptor NKG2D in autoimmunity
Belle, T. L. V., & von Herrath, M. G. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.023 · Cited by 55
Ortuño‐Sahagún, D., Márquez-Aguirre, A. L., Quintero-Fabián, S., López-Roa, R. I., & Rojas-Mayorquín, A. E. (2012) · PPAR Research · doi:10.1155/2012/318613 · Cited by 54
Metabolic Interaction of Helicobacter pylori Infection and Gut Microbiota
Yang, Y., & Sheu, B. (2016) · Microorganisms · doi:10.3390/microorganisms4010015 · Cited by 54
Inorganic nanoparticles and the microbiome
Qiu, K., Durham, P. G., & Anselmo, A. C. (2018) · Nano Research · doi:10.1007/s12274-018-2137-2 · Cited by 54
Hu, Y., Peng, J., Li, F., Wong, F. S., & Li, W. (2018) · Scientific Reports · doi:10.1038/s41598-018-33571-z · Cited by 54
Self-citationRole of the intestinal microbiome in autoimmune diseases and its use in treatments
Marietta, E. V., Horwath, I. E., Balakrishnan, B., & Taneja, V. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.10.005 · Cited by 55
Komorowski, A. S., & Pezo, R. C. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05472-w · Cited by 55
Jia, P., Junaid, M., Wen, P.-P., Yang, Y., Li, W.-G., Yang, X., & Pei, D. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.116925 · Cited by 54
Toll-like receptors in kidney disease
Smith, K. D. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32832a1d5f · Cited by 54
Genetic modification of iron metabolism in mice affects the gut microbiota
Buhnik-Rosenblau, K., Moshe-Belizowski, S., Danin-Poleg, Y., & Meyron-Holtz, E. G. (2012) · BioMetals · doi:10.1007/s10534-012-9555-5 · Cited by 53
Can functional oligosaccharides reduce the risk of diabetes mellitus?
Zhu, D., Yan, Q., Liu, J., Wu, X., & Jiang, Z. (2019) · The FASEB Journal · doi:10.1096/fj.201802802rrr · Cited by 53
Safety of vaccine adjuvants: Focus on autoimmunity
van der Laan, J. W., Gould, S., & Tanir, J. Y. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.01.073 · Cited by 53
Type 1 diabetes and gut microbiota: Friend or foe?
Hu, C., Wong, F. S., & Li, W. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.02.006 · Cited by 55
Self-citationRole of gut microbiota in graft-versus-host disease
Murphy, S. F., & Nguyen, V. H. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.580476 · Cited by 54
Experimental design considerations in microbiota/inflammation studies
Moore, R. J., & Stanley, D. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.41 · Cited by 53
Metadata
- Authors
- Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., Gordon, J. I., & Chervonsky, A. V.
- Affiliations
- Washington University in St. Louis (US)
- University of Chicago (US)
- Jackson Laboratory (US)
- Yale University (US)
- University of Bristol (GB)
- University of California, San Francisco (US)
- Corresponding author
- Chervonsky, Alexander V.
- ORCID
- Venue
- Nature
- Published
- 2008-09-21
- Volume
- 455
- Issue
- 7216
- Pages
- 1109-1113
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2574766
- OpenAlex
- W2148067809
- Cited by
- 1,921
- References
- 39
- Citations by year
- 2026: 23 · 2025: 49 · 2024: 75 · 2023: 69 · 2022: 105 · 2021: 86 · 2020: 112 · 2019: 137 · 2018: 134 · 2017: 128 · 2016: 141 · 2015: 137 · 2014: 138 · 2013: 119 · 2012: 132
- FWCI
- 62.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R37AI046643)
- National Institute of Diabetes and Digestive and Kidney Diseases (R37DK030292, DK-30292, DK 45735, DK063452, R21DK063452, DK 70977, DK42086, R01DK070977, P30DK063720, P30DK042086, P30DK056341, R01DK030292, P30DK045735)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- type 1 diabetes, innate immunity, gut microbiota, MyD88, Toll-like receptors, NOD mice, germ-free mice, commensal bacteria, autoimmune disease susceptibility, microbial products, mycobacteria, disease prevention, beta cell destruction, host-microbe interactions
- MeSH terms
- Animals, Bacteria, Diabetes Mellitus, Type 1, Female, Immunity, Innate, Interferon-gamma, Intestines, Islets of Langerhans, Male, Molecular Sequence Data, Phylogeny, Specific Pathogen-Free Organisms, Time Factors, Mice, SCID, Mice, Inbred NOD, Mice, Knockout, CD8-Positive T-Lymphocytes, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
